drugset / Trial / NCT00004420
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
Completed
50 enrolled
FDA Office of Orphan Products Development
University of Massachusetts, Worcester · collab
RandomizedCrossoverDouble-blindTreatment
Summary
OBJECTIVES: I. Determine the efficacy and safety of gammalinolenic acid in the treatment of childhood arthritis.
Timeline
- Start
- 1994-09
- Primary completion
- —
- Completion
- 1999-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GAMOLENIC ACID | Small molecule | — | Oral |